Specialty Retail
Compare Stocks
4 / 10Stock Comparison
WOOF vs IDXX vs ZTS vs CHWY
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Specialty Retail
WOOF vs IDXX vs ZTS vs CHWY — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Specialty Retail | Medical - Diagnostics & Research | Drug Manufacturers - Specialty & Generic | Specialty Retail |
| Market Cap | $752M | $45.45B | $36.86B | $9.80B |
| Revenue (TTM) | $5.96B | $4.45B | $9.51B | $12.35B |
| Net Income (TTM) | $9M | $1.10B | $2.64B | $151M |
| Gross Margin | 38.7% | 62.1% | 70.8% | 29.5% |
| Operating Margin | 2.0% | 31.6% | 37.9% | 1.3% |
| Forward P/E | 18.8x | 39.5x | 12.4x | 27.0x |
| Total Debt | $1.37B | $1.08B | $9.49B | $502M |
| Cash & Equiv. | $257M | $180M | $2.31B | $596M |
WOOF vs IDXX vs ZTS vs CHWY — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 21 | May 26 | Return |
|---|---|---|---|
| Petco Health and We… (WOOF) | 100 | 10.6 | -89.4% |
| IDEXX Laboratories,… (IDXX) | 100 | 119.5 | +19.5% |
| Zoetis Inc. (ZTS) | 100 | 56.6 | -43.4% |
| Chewy, Inc. (CHWY) | 100 | 23.2 | -76.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: WOOF vs IDXX vs ZTS vs CHWY
Each card shows where this stock fits in a portfolio — not just who wins on paper.
WOOF lags the leaders in this set but could rank higher in a more targeted comparison.
IDXX carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 5.6% 10Y total return vs ZTS's 107.3%
- 10.4% revenue growth vs WOOF's -2.5%
- +17.6% vs ZTS's -42.7%
- 32.6% ROA vs WOOF's 0.2%, ROIC 42.5% vs 2.9%
ZTS is the #2 pick in this set and the best alternative if sleep-well-at-night and valuation efficiency is your priority.
- Lower volatility, beta 0.90, current ratio 3.03x
- PEG 1.04 vs IDXX's 2.76
- Beta 0.90, yield 2.3%, current ratio 3.03x
- Lower P/E (12.4x vs 27.0x)
CHWY is the clearest fit if your priority is income & stability and growth exposure.
- beta 0.70
- Rev growth 6.4%, EPS growth 8.9%, 3Y rev CAGR 9.8%
- Beta 0.70 vs IDXX's 1.35
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.4% revenue growth vs WOOF's -2.5% | |
| Value | Lower P/E (12.4x vs 27.0x) | |
| Quality / Margins | 27.8% margin vs WOOF's 0.2% | |
| Stability / Safety | Beta 0.70 vs IDXX's 1.35 | |
| Dividends | 2.3% yield; 13-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +17.6% vs ZTS's -42.7% | |
| Efficiency (ROA) | 32.6% ROA vs WOOF's 0.2%, ROIC 42.5% vs 2.9% |
WOOF vs IDXX vs ZTS vs CHWY — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
WOOF vs IDXX vs ZTS vs CHWY — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
IDXX leads in 2 of 6 categories
ZTS leads 1 • WOOF leads 1 • CHWY leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ZTS leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CHWY is the larger business by revenue, generating $12.3B annually — 2.8x IDXX's $4.4B. ZTS is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to WOOF's 0.2%. On growth, IDXX holds the edge at +14.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $6.0B | $4.4B | $9.5B | $12.3B |
| EBITDAEarnings before interest/tax | $317M | $1.5B | $4.0B | $313M |
| Net IncomeAfter-tax profit | $9M | $1.1B | $2.6B | $151M |
| Free Cash FlowCash after capex | $286M | $845M | $2.1B | $463M |
| Gross MarginGross profit ÷ Revenue | +38.7% | +62.1% | +70.8% | +29.5% |
| Operating MarginEBIT ÷ Revenue | +2.0% | +31.6% | +37.9% | +1.3% |
| Net MarginNet income ÷ Revenue | +0.2% | +24.6% | +27.8% | +1.2% |
| FCF MarginFCF ÷ Revenue | +4.8% | +19.0% | +22.5% | +3.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.4% | +14.3% | +1.9% | +8.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +81.6% | +16.6% | +0.7% | -79.4% |
Valuation Metrics
WOOF leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 14.5x trailing earnings, ZTS trades at a 83% valuation discount to WOOF's 86.8x P/E. Adjusting for growth (PEG ratio), ZTS offers better value at 1.21x vs IDXX's 3.06x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $752M | $45.4B | $36.9B | $9.8B |
| Enterprise ValueMkt cap + debt − cash | $1.9B | $46.3B | $44.0B | $9.7B |
| Trailing P/EPrice ÷ TTM EPS | 86.75x | 43.75x | 14.50x | 25.99x |
| Forward P/EPrice ÷ next-FY EPS est. | 18.76x | 39.45x | 12.43x | 27.02x |
| PEG RatioP/E ÷ EPS growth rate | — | 3.06x | 1.21x | — |
| EV / EBITDAEnterprise value multiple | 5.89x | 31.60x | 10.78x | 42.76x |
| Price / SalesMarket cap ÷ Revenue | 0.13x | 10.56x | 3.89x | 0.83x |
| Price / BookPrice ÷ Book value/share | 0.68x | 28.75x | 11.63x | 38.99x |
| Price / FCFMarket cap ÷ FCF | 2.39x | 43.14x | 16.14x | 21.67x |
Profitability & Efficiency
IDXX leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
IDXX delivers a 70.9% return on equity — every $100 of shareholder capital generates $71 in annual profit, vs $1 for WOOF. IDXX carries lower financial leverage with a 0.67x debt-to-equity ratio, signaling a more conservative balance sheet compared to ZTS's 2.85x.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +0.8% | +70.9% | +62.4% | +38.8% |
| ROA (TTM)Return on assets | +0.2% | +32.6% | +17.5% | +4.8% |
| ROICReturn on invested capital | +2.9% | +42.5% | +26.9% | +28.0% |
| ROCEReturn on capital employed | +3.0% | +61.4% | +29.9% | +12.0% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 7 | 7 |
| Debt / EquityFinancial leverage | 1.18x | 0.67x | 2.85x | 1.92x |
| Net DebtTotal debt minus cash | $1.1B | $897M | $7.2B | -$93M |
| Cash & Equiv.Liquid assets | $257M | $180M | $2.3B | $596M |
| Total DebtShort + long-term debt | $1.4B | $1.1B | $9.5B | $502M |
| Interest CoverageEBIT ÷ Interest expense | 0.95x | 35.55x | 11.33x | 35.37x |
Total Returns (Dividends Reinvested)
IDXX leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IDXX five years ago would be worth $10,513 today (with dividends reinvested), compared to $1,154 for WOOF. Over the past 12 months, IDXX leads with a +17.6% total return vs ZTS's -42.7%. The 3-year compound annual growth rate (CAGR) favors IDXX at 5.6% vs WOOF's -35.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -3.5% | -14.6% | -29.8% | -29.4% |
| 1-Year ReturnPast 12 months | -14.1% | +17.6% | -42.7% | -38.3% |
| 3-Year ReturnCumulative with dividends | -73.0% | +17.9% | -49.8% | -29.2% |
| 5-Year ReturnCumulative with dividends | -88.5% | +5.1% | -44.4% | -66.7% |
| 10-Year ReturnCumulative with dividends | -90.6% | +556.2% | +107.3% | -32.4% |
| CAGR (3Y)Annualised 3-year return | -35.4% | +5.6% | -20.5% | -10.9% |
Risk & Volatility
Evenly matched — IDXX and CHWY each lead in 1 of 2 comparable metrics.
Risk & Volatility
CHWY is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than IDXX's 1.35 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IDXX currently trades 74.3% from its 52-week high vs CHWY's 48.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.92x | 1.35x | 0.90x | 0.70x |
| 52-Week HighHighest price in past year | $4.51 | $769.98 | $172.23 | $48.62 |
| 52-Week LowLowest price in past year | $2.24 | $471.74 | $85.31 | $22.74 |
| % of 52W HighCurrent price vs 52-week peak | +61.0% | +74.3% | +50.7% | +48.7% |
| RSI (14)Momentum oscillator 0–100 | 42.5 | 52.1 | 34.9 | 41.4 |
| Avg Volume (50D)Average daily shares traded | 2.6M | 533K | 3.7M | 7.7M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: WOOF as "Hold", IDXX as "Buy", ZTS as "Hold", CHWY as "Buy". Consensus price targets imply 76.3% upside for CHWY (target: $42) vs 30.5% for WOOF (target: $4). ZTS is the only dividend payer here at 2.29% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $3.59 | $773.13 | $143.00 | $41.71 |
| # AnalystsCovering analysts | 25 | 22 | 30 | 38 |
| Dividend YieldAnnual dividend ÷ price | — | — | +2.3% | — |
| Dividend StreakConsecutive years of raises | — | — | 13 | — |
| Dividend / ShareAnnual DPS | — | — | $2.00 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.7% | +8.8% | +9.6% |
IDXX leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). ZTS leads in 1 (Income & Cash Flow). 1 tied.
WOOF vs IDXX vs ZTS vs CHWY: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is WOOF or IDXX or ZTS or CHWY a better buy right now?
For growth investors, IDEXX Laboratories, Inc.
(IDXX) is the stronger pick with 10. 4% revenue growth year-over-year, versus -2. 5% for Petco Health and Wellness Company, Inc. (WOOF). Zoetis Inc. (ZTS) offers the better valuation at 14. 5x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate IDEXX Laboratories, Inc. (IDXX) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — WOOF or IDXX or ZTS or CHWY?
On trailing P/E, Zoetis Inc.
(ZTS) is the cheapest at 14. 5x versus Petco Health and Wellness Company, Inc. at 86. 8x. On forward P/E, Zoetis Inc. is actually cheaper at 12. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Zoetis Inc. wins at 1. 04x versus IDEXX Laboratories, Inc. 's 2. 76x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — WOOF or IDXX or ZTS or CHWY?
Over the past 5 years, IDEXX Laboratories, Inc.
(IDXX) delivered a total return of +5. 1%, compared to -88. 5% for Petco Health and Wellness Company, Inc. (WOOF). Over 10 years, the gap is even starker: IDXX returned +556. 2% versus WOOF's -90. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — WOOF or IDXX or ZTS or CHWY?
By beta (market sensitivity over 5 years), Chewy, Inc.
(CHWY) is the lower-risk stock at 0. 70β versus IDEXX Laboratories, Inc. 's 1. 35β — meaning IDXX is approximately 91% more volatile than CHWY relative to the S&P 500. On balance sheet safety, IDEXX Laboratories, Inc. (IDXX) carries a lower debt/equity ratio of 67% versus 3% for Zoetis Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — WOOF or IDXX or ZTS or CHWY?
By revenue growth (latest reported year), IDEXX Laboratories, Inc.
(IDXX) is pulling ahead at 10. 4% versus -2. 5% for Petco Health and Wellness Company, Inc. (WOOF). On earnings-per-share growth, the picture is similar: Chewy, Inc. grew EPS 893. 4% year-over-year, compared to 10. 1% for Zoetis Inc.. Over a 3-year CAGR, CHWY leads at 9. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — WOOF or IDXX or ZTS or CHWY?
Zoetis Inc.
(ZTS) is the more profitable company, earning 28. 2% net margin versus 0. 2% for Petco Health and Wellness Company, Inc. — meaning it keeps 28. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ZTS leads at 38. 0% versus 0. 9% for CHWY. At the gross margin level — before operating expenses — ZTS leads at 70. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is WOOF or IDXX or ZTS or CHWY more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Zoetis Inc. (ZTS) is the more undervalued stock at a PEG of 1. 04x versus IDEXX Laboratories, Inc. 's 2. 76x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Zoetis Inc. (ZTS) trades at 12. 4x forward P/E versus 39. 5x for IDEXX Laboratories, Inc. — 27. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CHWY: 76. 3% to $41. 71.
08Which pays a better dividend — WOOF or IDXX or ZTS or CHWY?
In this comparison, ZTS (2.
3% yield) pays a dividend. WOOF, IDXX, CHWY do not pay a meaningful dividend and should not be held primarily for income.
09Is WOOF or IDXX or ZTS or CHWY better for a retirement portfolio?
For long-horizon retirement investors, Zoetis Inc.
(ZTS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 90), 2. 3% yield, +107. 3% 10Y return). Both have compounded well over 10 years (ZTS: +107. 3%, WOOF: -90. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between WOOF and IDXX and ZTS and CHWY?
These companies operate in different sectors (WOOF (Consumer Cyclical) and IDXX (Healthcare) and ZTS (Healthcare) and CHWY (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: WOOF is a small-cap quality compounder stock; IDXX is a mid-cap quality compounder stock; ZTS is a mid-cap deep-value stock; CHWY is a small-cap quality compounder stock. ZTS pays a dividend while WOOF, IDXX, CHWY do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.